Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 60,000 shares at $0.74 ($45K) on 2022-12-13, disclosed to the SEC on 2022-12-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.74 | 50,000 | $37K | 82.6% |
| 2 | $0.78 | 10,000 | $8K | 17.4% |
| Total | $0.75 avg | 60,000 | $45K | 100% |
| Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |
| CRVS | BUY | 2022-06-28 | $10K | — | Filing → |